Synthesis of tetracyclic 4H‐benzo[5,6]chromeno[3,4‐d]oxazoles via palladium‐catalyzed intramolecular direct heteroarylation DOI Open Access

Sujeet Kumar,

Km Kajol,

Prakash Nayak

et al.

Chemistry - An Asian Journal, Journal Year: 2022, Volume and Issue: 18(3)

Published: Dec. 15, 2022

Abstract We report a palladium‐catalyzed intramolecular direct heteroarylation of oxazole tethered β ‐naphthols to access corresponding tetracyclic 4 H ‐benzo[5,6]chromeno[3,4‐ d ]oxazoles. Various functional groups are well tolerated and furnished the desired products in good excellent yields under present reaction conditions. The scale‐up synthetic utility resulting molecules have been demonstrated. Moreover, UV/vis absorption fluorescence emission properties evaluated for these polyheterocyclic compounds.

Language: Английский

Natural products and derivatives for breast cancer treatment: From drug discovery to molecular mechanism DOI Creative Commons
Jing Zhang, Yongya Wu, Yanhong Li

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 129, P. 155600 - 155600

Published: April 7, 2024

Breast cancer stands as the most common malignancy among women globally and a leading cause of cancer-related mortality. Conventional treatments, such surgery, hormone therapy, radiotherapy, chemotherapy, small-molecule targeted often fall short addressing complexity heterogeneity certain breast subtypes, to drug resistance metastatic progression. Thus, search for novel therapeutic targets agents is imperative. Given their low toxicity abundant variety, natural products derivatives are increasingly considered valuable sources anticancer drugs. This review aims elucidate pharmacological impacts underlying mechanisms active compounds found in select derivatives, primarily focusing on treatment. It intends underscore potential these substances combating guide future research directions development product-based therapeutics. We conducted comprehensive searches electronic databases PubMed, Web Science, Scopus until October 2023, using keywords 'breast cancer', 'natural products', 'derivatives', 'mechanism', 'signaling pathways', various keyword combinations. The presents spectrum phytochemicals, including but not limited flavonoids, polyphenols, alkaloids, examines actions animal cellular models cancer. effects manifested through diverse mechanisms, induction cell death via apoptosis autophagy, suppression tumor angiogenesis. An increasing array proving effective against Future strategies can benefit from strategic enhancement properties compounds, optimization action, improved bioavailability, minimized side effects. forthcoming should prioritize facets maximize

Language: Английский

Citations

24

Synthesis and Biological Studies of Benzo[b]furan Derivatives: A Review from 2011 to 2022 DOI Creative Commons
Lizeth Arce-Ramos, Juan‐Carlos Castillo, Diana Becerra

et al.

Pharmaceuticals, Journal Year: 2023, Volume and Issue: 16(9), P. 1265 - 1265

Published: Sept. 6, 2023

The importance of the benzo[b]furan motif becomes evident in remarkable results numerous biological investigations, establishing its potential as a robust therapeutic option. This review presents an overview synthesis and exhaustive studies conducted on derivatives from 2011 to 2022, accentuating their exceptional promise anticancer, antibacterial, antifungal agents. Initially, discussion focuses chemical synthesis, molecular docking simulations, both vitro vivo studies. Additionally, we provide analysis intricate interplay between structure activity, thereby facilitating comparisons profoundly emphasizing applications within realms drug discovery medicinal chemistry.

Language: Английский

Citations

18

Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship DOI
Zhen Wang,

Yongxia Xiong,

Ying Peng

et al.

European Journal of Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 247, P. 115031 - 115031

Published: Dec. 17, 2022

Language: Английский

Citations

25

PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders DOI Creative Commons
Shuqiang Chen,

Kaijian Bi,

Huixin Liang

et al.

Journal of Advanced Research, Journal Year: 2023, Volume and Issue: 63, P. 219 - 230

Published: Nov. 1, 2023

Natural products (NPs) play a crucial role in the development of therapeutic drugs. However, it is still highly challenging to identify targets NPs. Besides, NPs usually exert their pharmacological activities via acting on multiple or pathways, which also poses great difficulties for target identification

Language: Английский

Citations

15

Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer DOI
Eun Seo Bae,

Junhwa Hong,

Yijae Lim

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(17), P. 14885 - 14911

Published: Aug. 16, 2024

As an obstinate cancer pancreatic (PC) poses a major challenge due to limited treatment options which include resection surgery, radiation therapy, and gemcitabine-based chemotherapy. In cells, protein kinase C βI (PKCβI) participates in diverse cellular processes, including cell proliferation, invasion, apoptotic pathways. the present study, we created scaffold develop PKCβI inhibitors using evodiamine-based synthetic molecules. Among candidate inhibitors, Evo312 exhibited highest antiproliferative efficacy against PC PANC-1, acquired gemcitabine-resistant PANC-GR. Additionally, robustly inhibited activity. Mechanistically, effectively suppressed upregulation of expression, leading induction cycle arrest apoptosis PANC-GR cells. Furthermore, exerted antitumor activity cell-implanted xenograft mouse model. These findings position as promising lead compound for overcoming gemcitabine resistance through novel mechanisms.

Language: Английский

Citations

4

Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy DOI
Ziyi Liang, Yuqing Wang, Honghua Zhang

et al.

European Journal of Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 239, P. 114530 - 114530

Published: June 15, 2022

Language: Английский

Citations

16

Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis DOI Open Access
Che‐Yuan Hu, Hung‐Tsung Wu, Yan‐Shen Shan

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(7), P. 6021 - 6021

Published: March 23, 2023

Evodiamine (EVO) exhibits anti-cancer activity through the inhibition of cell proliferation; however, little is known about its underlying mechanism. To determine whether ferroptosis involved in therapeutic effects EVO, we investigated critical factors, such as lipid peroxidation levels and glutathione peroxidase 4 (GPX4) expression, under EVO treatment. Our results showed that inhibited proliferation poorly differentiated, high-grade bladder cancer TCCSUP cells a dose- time-dependent manner. Lipid peroxides were detected by fluorescence microscopy after exposure to EVO. GPX4, which catalyzes conversion prevent from undergoing ferroptosis, was decreased dose-dependently Given features iron dependency lipid-peroxidation-driven death chelator deferoxamine (DFO) used suppress EVO-induced ferroptosis. The peroxide level significantly when treated with DFO prior also attenuated death. Co-treatment pan-caspase inhibitor or necroptosis did not alleviate These indicate induces rather than apoptosis necroptosis. Furthermore, suppressed migratory ability, expression mesenchymal markers, increased epithelial marker determined transwell migration assay Western blotting. tumor xenograft model confirmed on growth EMT. In conclusion, novel inducer for activating may be potential agent cancer.

Language: Английский

Citations

8

Discovery of Indolo[3,2-c]isoquinoline Derivatives as Novel Top1/2 Dual Inhibitors with Orally Efficacious Antitumor Activity and Low Toxicity DOI

Bichuan Wang,

Shanchao Wu,

Shuolei Jia

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(16), P. 14155 - 14174

Published: Aug. 6, 2024

Topoisomerase (Top) inhibitors used in clinical cancer treatments are limited because of their toxicity and severe side effects. Noteworthily, Top1/2 dual overcome the compensatory effect between Top1 2 to exhibit stronger antitumor efficacies. In this study, a series indolo[3,2-

Language: Английский

Citations

3

An A-ring substituted evodiamine derivative with potent anticancer activity against human non-small cell lung cancer cells by targeting heat shock protein 70 DOI
Hye‐Young Min,

Yijae Lim,

Hyuk-Jin Kwon

et al.

Biochemical Pharmacology, Journal Year: 2023, Volume and Issue: 211, P. 115507 - 115507

Published: March 21, 2023

Language: Английский

Citations

7

Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design DOI

Shivani,

Towhidur Rahaman, Sandeep Chaudhary

et al.

Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(9), P. 104115 - 104115

Published: July 26, 2024

Language: Английский

Citations

2